Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma
出版年份 2020 全文链接
标题
Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma
作者
关键词
Hodgkin lymphoma, Trabectedin, Doxorubicin, Tumor microenvironment, Tumor associated macrophages
出版物
CANCER LETTERS
Volume 500, Issue -, Pages 182-193
出版商
Elsevier BV
发表日期
2020-12-15
DOI
10.1016/j.canlet.2020.12.015
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
- (2019) Maria Cucè et al. Journal of Hematology & Oncology
- Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It
- (2019) Donatella Aldinucci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of necroptosis in cancer biology and therapy
- (2019) Yitao Gong et al. Molecular Cancer
- Trabectedin reveals a strategy of immunomodulation in chronic lymphocytic leukemia
- (2019) Priyanka Banerjee et al. Cancer Immunology Research
- Fibroblasts in Nodular Sclerosing Classical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury
- (2019) Katrin Bankov et al. Cancers
- Enriching cancer pharmacology with drugs of marine origin
- (2019) Paula C. Jimenez et al. BRITISH JOURNAL OF PHARMACOLOGY
- High CD206 levels in Hodgkin lymphoma‐educated macrophages are linked to matrix‐remodeling and lymphoma dissemination
- (2019) Annekatrin Arlt et al. Molecular Oncology
- Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management
- (2018) Stephen M. Ansell AMERICAN JOURNAL OF HEMATOLOGY
- Management of relapsed/refractory classical Hodgkin lymphoma in transplant-ineligible patients
- (2018) Neha Mehta-Shah et al. BLOOD
- Mass cytometry of Hodgkin lymphoma reveals a CD4+exhausted T-effector and T-regulatory cell rich microenvironment
- (2018) Fathima Zumla Cader et al. BLOOD
- Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma
- (2018) Filippo Spriano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype
- (2018) Bastian Dörsam et al. Frontiers in Immunology
- Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
- (2018) Tasuku Kiyuna et al. BMC CANCER
- Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma
- (2018) Laura Carminati et al. CARCINOGENESIS
- Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530
- (2018) Silvia L. Locatelli et al. CLINICAL CANCER RESEARCH
- CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
- (2018) Naike Casagrande et al. HAEMATOLOGICA
- The efficacy of trabectedin in treating ovarian cancer
- (2017) Eleonora Teplinsky et al. EXPERT OPINION ON PHARMACOTHERAPY
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
- (2017) Marco Ruella et al. Cancer Discovery
- Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma
- (2017) Frederik Wein et al. Cancer Immunology Research
- Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma
- (2017) Yevette McGovern et al. Frontiers in Oncology
- Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance
- (2016) Donatella Aldinucci et al. CANCER LETTERS
- Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma
- (2016) Manuel Gotti et al. HEMATOLOGICAL ONCOLOGY
- Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia
- (2016) G Lohmann et al. LEUKEMIA
- A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia
- (2016) L Mannarino et al. PHARMACOGENOMICS JOURNAL
- Unique features of trabectedin mechanism of action
- (2015) Annette K. Larsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients
- (2015) Tamar Tadmor et al. MAYO CLINIC PROCEEDINGS
- Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study
- (2014) Ji-Young Choe et al. BMC CANCER
- Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
- (2014) M D’Incalci et al. BRITISH JOURNAL OF CANCER
- Macrophages and Dendritic Cells as Actors in the Immune Reaction of Classical Hodgkin Lymphoma
- (2014) Christiane Silke Tudor et al. PLoS One
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
- (2013) Agnieszka Kaczmarek et al. IMMUNITY
- Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols
- (2012) Wesley Greaves et al. Journal of Hematology & Oncology
- Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
- (2010) C. Steidl et al. BLOOD
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
- T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
- (2009) A. Di Stasi et al. BLOOD
- Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions
- (2007) Donatella Aldinucci et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now